Market Place
Sourcing Support
Elpida (elsulfavirine) becomes the preferred first line therapy for treatment
02 Feb 2021 //
PRNEWSWIRE
Viriom Initiates Phase 2 Clinical Study of Elsulfavirine Treatment of COVID-19
08 Apr 2020 //
PRNEWSWIRE
Viriom Launches Reproductive Toxicity Studies for Elpida
03 Dec 2019 //
PR NEWSWIRE
Viriom Initiates Phase 1 Clinical Trial of Once Monthly Injectable HIV Treatment
20 Dec 2018 //
PR NEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.